Background: Respiratory syncytial virus (RSV) infection poses a substantial clinical burden
among infants and young children. We sought to determine the health care costs of …

Background Limited data are available on the economic costs of respiratory syncytial virus
(RSV) infections among infants and young children in the United States. Methods We …

Background This study evaluates the long-term respiratory syncytial virus (RSV) burden
among preterm and full-term infants in the United States. Methods Infants with birth …

Objective: Infection with respiratory syncytial virus (RSV), which causes lower respiratory
tract infections, is the leading cause of hospitalization among children< 1 year old in the …

Background Despite several studies that have estimated the economic impact of Respiratory
Syncytial Virus (RSV) in infants, limited data are available on healthcare resource use and …

Background Respiratory syncytial virus (RSV) is the leading cause of hospitalizations in
United States infants aged< 1 year, but research has focused on select populations …

Background Respiratory syncytial virus (RSV) is the primary cause of respiratory tract
infections in infants; however, current burden estimates report only the short-term effects of …

Background: Respiratory syncytial virus (RSV) is the leading viral cause of death in infants
younger than 1 year. In July 2014, the American Academy of Pediatrics (AAP) Committee on …

OBJECTIVE: The objective of this study was to quantify time spent plus out-of-pocket costs
associated with confirmed respiratory syncytial virus (RSV) hospitalization of infants not …

Respiratory syncytial virus (RSV) is the most common cause of pediatric acute lower
respiratory tract infection worldwide. Detailed data on the health and economic burden of …